ADAkan Das

Akan Das

*This is an algorithmically generated author record based on publicly available information.

Akan Das has a total of 8 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Phytochemical Insights into Citrus limon (L.) Osbeck (Kaji Nemu) of Assam as a Potential Natural Modulator of Hyperthyroidism: A Structure-Based and Experimental Approach

    by Raihana Yashmin, Rubina Ahmed, Taslema Begum, Jogen Chandra Kalita, Akan Das, Himakshi Sarma

    Hyperthyroidism is characterized by impaired hormone biosynthesis and dysregulated receptor signaling, and remains a pressing clinical concern as current drugs such as methimazole are often associated with adverse effects and limited efficacy. In this study, we explored the methanolic peel extract of Citrus limon (L.) Osbeck (Kaji Nemu), a distinctive citrus variety from Northeast India, is a potential source of natural therapeutic compounds. LC-MS profiling identified 55 phytochemicals, of which 27 drug-like candidates were shortlisted, alongside ADMET evaluations. Molecular docking revealed three lead compounds including 1-(3,4-Dimethylphenyl)-4-[(4-isopropylphenyl)sulfonyl]piperazine, 2 Benzylcyclohexanol and 2-[(1Z)-2-Methoxy-1-propenyl]-1,3,5-trimethylbenzene showing superior binding affinities with thyroid peroxidase (TPO: –8.2 kcal/mol), thyroid receptor [ ] (TR[ ]: –7.6 kcal/mol) and thyroid receptor [ ]1 (TR[ ]1: –7.7 kcal/mol), respectively, compared to methimazole. A detailed interaction analysis demonstrated extensive hydrogen bonding, hydrophobic, and [ ]-interactions, suggesting stable and versatile engagement within binding pockets. Molecular dynamics simulations further confirmed the protein-specific stabilizing effects of candidate ligands, with notable enhancement of backbone stability in TPO and TR[ ]1. ELISA-based enzyme quantification further supported the therapeutic relevance, with Kaji Nemu peel extract significantly reducing TPO levels in hyperthyroid tissue samples. Overall, the study highlights the translational potential of Kaji Nemu phytochemicals as multi-target modulators capable of simultaneously inhibiting thyroid hormone biosynthesis and regulating receptor activity. These findings position this indigenous citrus resource as a promising avenue for developing safer, plant-derived interventions for managing hyperthyroidism, paving the way for further in vitro and in vivo validations.

  • An Integrated Systematic Study Combining GC–MS, HPLC, Molecular Docking, and MD Simulation to Explore the Potential of Nothapodytes nimmoniana (J. Graham) Mabb. for the Management of PCOS

    by Rubina Ahmed, Raihana Yashmin, Jogen Chandra Kalita, Himakshi Sarma, Akan Das

    Polycystic ovary syndrome (PCOS) is a complex endocrine disorder characterized by hormonal imbalance, insulin resistance, and chronic inflammation, often leading to infertility and metabolic complications. This study explores the therapeutic potential of Nothapodytes nimmoniana , an ethnobotanically significant plant, for PCOS management. Methanolic leaf extracts of the plant were analyzed using GC–MS and HPLC, revealing the presence of several bioactive compounds, including vitamins D and E. These vitamins are well‐documented for their roles in improving insulin sensitivity, regulating hormonal levels, and reducing oxidative stress, making them valuable in alleviating PCOS symptoms. Through virtual screening and molecular docking, 4,4,5,8‐tetramethyl‐2,3‐dihydrochromen‐2‐ol was identified as a promising candidate with strong binding affinities to tumor necrosis factor‐alpha (TNF‐α) and human estrogenic receptor‐α (hER‐α), two key proteins implicated in PCOS pathogenesis. Molecular dynamics simulations further confirmed the stability and favorable interactions of this compound with the target proteins, indicating its potential as a lead molecule for drug development. The study highlights N. nimmoniana's pharmacological significance, emphasizing its anti‐inflammatory, antioxidant, and therapeutic properties. Integrating computational and experimental approaches, it provides a foundation for PCOS treatment. Future in vivo and clinical studies are needed to validate its efficacy and safety, promoting plant‐derived compounds for innovative, sustainable therapies.